Ethical Issues in Alzheimer’s Disease Clinical Trials: Genetic and Biomarker Disclosure

Description: A discussion of the ethical issues that arise in clinical trials for potential Alzheimer’s disease treatments, with special focus on the considerations that factor into learning one’s genetic status
Runtime: 00:22:46

Speaker: Jason Karlawish, MD
Speaker title: Professor of Medicine, Medical Ethics and Health Policy
Speaker organization: University of Pennsylvania

Speaker: Joshua Grill, PhD
Speaker title: Associate Professor of Psychiatry and Human Behavior
Speaker organization: University of California, Irvine

Event: 2016 DIAD Family Conference: Too Young to Forget
Location: Toronto, Ontario, Canada
Year: 2016

Search tags: ethics, biomarkers, genetic information, privacy, informed consent, risk and safety, trial participation, preclinial Alzheimer’s, A4 trial, stigma